Roivant Sciences
ROIV
337 hedge funds and large institutions have $7.59B invested in Roivant Sciences in 2025 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 125 increasing their positions, 95 reducing their positions, and 56 closing their positions.
157% more call options, than puts
Call options by funds: $114M | Put options by funds: $44.4M
32% more repeat investments, than reductions
Existing positions increased: 125 | Existing positions reduced: 95
31% more capital invested
Capital invested by funds: $5.8B → $7.59B (+$1.79B)
15% more funds holding in top 10
Funds holding in top 10: 13 → 15 (+2)
5% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 56
0% more funds holding
Funds holding: 337 → 337 (0)
2.23% less ownership
Funds ownership: 75.68% → 73.45% (-2.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$65.1M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$63.8M |
| 3 |
PA
Perceptive Advisors
New York
|
+$50M |
| 4 |
SC
Stempoint Capital
New York
|
+$44.5M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$37.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
-$243M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$132M |
| 3 |
ACG
Anchorage Capital Group
New York
|
-$54.5M |
| 4 |
PP
Pertento Partners
London,
United Kingdom
|
-$35M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$29.1M |
ROIV Hedge Fund Activity: Q3 2025 in Review
337 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q3 2025, worth a combined $7.59B — up 31% from $5.8B a quarter earlier.
Buyers outnumbered sellers: 59 funds opened new ROIV positions and 56 closed out — a net gain of 3 holders — while 125 added to existing stakes and 95 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $65.1M. The largest seller was SB Investment Advisers (UK), cutting an estimated $243M.
- 337 institutional investors held Roivant Sciences (ROIV) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $7.59B of Roivant Sciences stock for Q3 2025, up 31% quarter-over-quarter.
- 59 funds opened new Roivant Sciences positions in Q3 2025 and 56 closed out, a net change of +3 holders.
- The largest Roivant Sciences buyer in Q3 2025 was Fidelity Investments, an estimated $65.1M added.
- The largest Roivant Sciences seller in Q3 2025 was SB Investment Advisers (UK), an estimated $243M sold.
Based on aggregated 13F filings for Q3 2025.